Vitality Watch

Dossier pubmed preclinical 01-nov-2026
Animal model, organoid, or cell-culture result — not yet human

Enabling Photoacoustic Imaging and Photothermal Elimination of Senescent Cells via an Activatable Theranostic Probe.

Key claim: An activatable theranostic probe, RPM-Gal, enables selective photoacoustic imaging and photothermal elimination of senescent cells in vivo via senescence-associated beta-galactosidase activation.

Abstract

Excessive accumulation of senescent cells disrupts tissue homeostasis, induces chronic inflammation and tumorigenesis, and ultimately accelerates senescence-associated dysfunction and malignant progression. Developing reliable tools for the detection and elimination of senescent cells is critical for the precise diagnosis and timely intervention of aging-associated diseases. However, existing senolytic theranostic probes suffer from oxygen-dependent photodynamic therapy (PDT) efficacy and the inherent limitations of fluorescence imaging in penetration depth and spatial resolution. Herein, we report the first theranostic probe RPM-Gal that integrates senescence-associated β-galactosidase-activated photoacoustic imaging and photothermal elimination of senescent cells. RPM-Gal is assembled by tethering a β-D-galactopyranoside moiety to a rhodol-derived polymethine scaffold (RPM-OH) via a self-immolative benzyl spacer. In vitro tests demonstrate that RPM-Gal possesses an excellent photoacoustic response and outstanding photothermal behavior against β-galactosidase. It is found that the overexpressed β-galactosidase in senescent cells can specifically activate the PA signal and the PTT effect of RPM-Gal upon light irradiation. This probe has been further successfully implemented for PA imaging and photothermal elimination of senescent tumor cells in vivo, establishing a targeted avenue for effective senolytic therapy.

Why this matters

[animal-model] RPM-Gal couples a senescence-associated enzyme readout to photoacoustic imaging and photothermal cell elimination in preclinical in vivo work, linking detection and intervention within one probe. [animal-model] This is a proof of concept for imaging-guided senescent-cell targeting, not validation of a whole-body aging measure or evidence that changing its signal improves human health or reverses aging.

Source

Link

Briefing card

Enabling Photoacoustic Imaging and Photothermal Elimination of Senescent Cells via an Activatable Theranostic Probe.
Stage: preclinical · pubmed · 01-nov-2026

An activatable theranostic probe, RPM-Gal, enables selective photoacoustic imaging and photothermal elimination of senescent cells in vivo via senescence-associated beta-galactosidase activation.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1021/acs.analchem.6c05223

build build 880 · 2bcef25 · 2026-11-18